BioScrip (BIOS) Misses Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts BIOS Hot Sheet
Price: $10.80 --0%
Financial Fact:
Selling, general and administrative expenses: 42.73M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Selling, general and administrative expenses: 42.73M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
BioScrip (NASDAQ: BIOS) reported Q1 EPS of ($0.17), $0.05 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $238.5 million versus the consensus estimate of $232.38 million.
For earnings history and earnings-related data on BioScrip (BIOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
